Headline News about Stoke Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/741125/scientist-looking-through-microscope-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/25/verizon_communications_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Stoke Therapeutics's Future
June 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Stoke Therapeutics
June 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/25/stok.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Where Stoke Therapeutics Stands With Analysts
May 23, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Stoke Therapeutics: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 7 Analyst Ratings Have To Say About Stoke Therapeutics
April 26, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/07/25/alaska_air_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
6 Analysts Have This to Say About Stoke Therapeutics
March 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/24/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/21/scholastic_-_logo.jpg?width=1200&height=800&fit=crop)
Expert Ratings for Stoke Therapeutics
January 11, 2023
Via Benzinga
Stoke Therapeutics Earnings Perspective: Return On Capital Employed
December 26, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/04/adobe_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image-yum_brands.png?width=1200&height=800&fit=crop)
Yum! Brands To Rally Around 20%? Here Are 10 Other Price Target Changes For Monday
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22772.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21987.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.